SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-060387
Filing Date
2021-05-04
Accepted
2021-05-03 19:00:45
Documents
14
Period of Report
2021-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114995d1_8k.htm   iXBRL 8-K 27096
2 EXHIBIT 99.1 tm2114995d1_ex99-1.htm EX-99.1 36054
6 GRAPHIC image_002.jpg GRAPHIC 2450
  Complete submission text file 0001104659-21-060387.txt   249398

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlgt-20210503.xsd EX-101.SCH 3184
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlgt-20210503_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlgt-20210503_pre.xml EX-101.PRE 22709
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2114995d1_8k_htm.xml XML 3479
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 856.697.1441
Teligent, Inc. (Filer) CIK: 0000352998 (see all company filings)

IRS No.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-08568 | Film No.: 21885229
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences